清洗
发表于 2025-3-25 03:52:38
http://reply.papertrans.cn/103/10276/1027504/1027504_21.png
钝剑
发表于 2025-3-25 08:09:17
http://reply.papertrans.cn/103/10276/1027504/1027504_22.png
减至最低
发表于 2025-3-25 12:26:28
http://reply.papertrans.cn/103/10276/1027504/1027504_23.png
易受刺激
发表于 2025-3-25 18:36:29
http://reply.papertrans.cn/103/10276/1027504/1027504_24.png
patriarch
发表于 2025-3-25 23:39:50
The Arterial-Alveolar Nitrogen Difference for the Assessment of Ventilation-Perfusion Mismatch and, hence, an increased alveolar-arterial oxygen partial pressure difference (D(A-a)O.)—at a given fraction of inspired oxygen (FiO.) and a stable cardiac output—are mainly attributed to ventilation-perfusion mismatch (low V./Q areas) and direct intrapulmonary right-to-left shunting. The discrimin
Vo2-Max
发表于 2025-3-26 02:38:21
http://reply.papertrans.cn/103/10276/1027504/1027504_26.png
菊花
发表于 2025-3-26 04:46:36
http://reply.papertrans.cn/103/10276/1027504/1027504_27.png
Aromatic
发表于 2025-3-26 10:28:03
http://reply.papertrans.cn/103/10276/1027504/1027504_28.png
为现场
发表于 2025-3-26 13:53:39
Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy, hypertrophy of the car-diomyocytes.. What is the role of ANG II in the development and maintenance of cardiovascular (CV) hypertrophy? In this chapter, we will seek for the answer by reviewing the current data on the prevention and regression of CV hypertrophy in association with pharmacologically induced inhibition of ANG II effects.
同音
发表于 2025-3-26 20:03:55
http://reply.papertrans.cn/103/10276/1027504/1027504_30.png